Enimmune corporation (6564) Stock Price & Analysis
6564 Stock Chart & Stats
- Day’s Range
- TWD 13.55 - TWD 14.20
- 52-Week Range
- TWD 13.55 - TWD 22.51
- Previous Close
- TWD 14.60
- Volume
- N/A
- Average Volume (3M)
- 44.97K
- Market Cap
- TWD 1.13B
- Enterprise Value
- N/A
- Total Cash (Recent Filing)
- TWD 193.45M
- Total Debt (Recent Filing)
- TWD 159.57M
- Price to Earnings (P/E)
- ―
- Beta
- 0.47
- Next Earnings
- N/A
- EPS Estimate
- N/A
- Next Dividend Ex-Date
- N/A
- Dividend Yield
- N/A
6564 FAQ
What was Enimmune corporation’s price range in the past 12 months?
What is Enimmune corporation’s market cap?
When is Enimmune corporation’s upcoming earnings report date?
Is Enimmune corporation overvalued?
Does Enimmune corporation pay dividends?
What is Enimmune corporation’s EPS estimate?
How many shares outstanding does Enimmune corporation have?
Which hedge fund is a major shareholder of Enimmune corporation?
What is the TipRanks Smart Score and how is it calculated?
Company Description
Enimmune corporation
Enimmune Corporation is a Taiwanese biopharmaceutical company primarily focused on the research, development, and commercialization of pharmaceutical products. Among its key offerings is Tuberculin PPD RT23 SSI, an approved diagnostic agent utilized in tuberculin tests to ascertain the presence of tuberculosis infection in patients. Beyond its existing products, Enimmune is heavily invested in developing vaccines aimed at combating a diverse array of infectious diseases. These include, but are not limited to, vaccines for enterovirus, pneumonia, norovirus, dengue fever, and Middle East Respiratory Syndrome Coronavirus (MERS-CoV). Established in 2014, the company maintains its headquarters in Taichung City, Taiwan.
- Sector
- General
- Industry
- Biotechnology
- CEO
- Zhe Wei Zhang
- Employees
- 27
- Website
- www.enimmune.com.tw
- Address
- No. 76, Section 2, Taipei, TPE, 106485, TW
Technical Analysis
Overall Consensus
| Indicator | Bullish | Neutral | Bearish |
|---|---|---|---|
| Overall Consensus | 6 | 2 | 14 |
| Technical Analysis | 6 | 2 | 2 |
| Moving Averages | 0 | 0 | 12 |

